Portfolio Holdings Detail for ISIN IE00B43HR379

Stock Name / Fund	iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	IHCU(GBX) LSE
ETF Ticker	IUHC(USD) LSE
ETF Ticker	QDVG(EUR) F
ETF Ticker	IHCU.LS(GBX) CXE
ETF Ticker	IUHC.LS(USD) CXE
ETF Ticker	IUHCz(USD) CXE
ETF Ticker	QDVG.DE(EUR) CXE
ETF Ticker	IHCU.L(GBP) LSE
ETF Ticker	IUHC.L(GBP) LSE

Holdings detail for ABBV

Show aggregate ABBV holdings

News associated with ABBV

Boost Your Portfolio With These Top-Ranked ETFs

With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00

AbbVie (NYSE:ABBV) Reaches New 12-Month High After Analyst Upgrade

AbbVie Inc. (NYSE:ABBV – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Thursday after Berenberg Bank upgraded the stock from a hold rating to a buy rating. Berenberg Bank now has a $270.00 price target on the stock, up from their previous price target of $170.00. AbbVie traded as […] - 2025-09-19 03:10:53

AbbVie (NYSE:ABBV) Upgraded by Berenberg Bank to Buy Rating

AbbVie (NYSE:ABBV – Get Free Report) was upgraded by investment analysts at Berenberg Bank from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, Marketbeat reports. The firm currently has a $270.00 price target on the stock, up from their previous price target of $170.00. Berenberg […] - 2025-09-19 02:24:45

Noteworthy Thursday Option Activity: ZS, CRM, ABBV

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Zscaler Inc (Symbol: ZS), where a total of 10,858 contracts have traded so far, representing approximately 1.1 million underlying shares. That amounts to about 58.1% of - 2025-09-18 16:21:04

Notable ETF Inflow Detected - ITOT, HD, ABBV, AMD

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P Total U.S. Stock Market ETF (Symbol: ITOT) where we have detected an approximate $179.9 million dollar inflow -- that's a 0.2% i - 2025-09-18 13:25:16

Guru Fundamental Report for ABBV

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks low volatility stocks that also have st - 2025-09-18 10:39:12

AbbVie (NYSE:ABBV) Trading Up 1.8% on Analyst Upgrade

AbbVie Inc. (NYSE:ABBV – Get Free Report) shares rose 1.8% on Wednesday after Berenberg Bank upgraded the stock from a hold rating to a buy rating. Berenberg Bank now has a $270.00 price target on the stock, up from their previous price target of $170.00. AbbVie traded as high as $221.55 and last traded at […] - 2025-09-18 03:08:42

ABBV Factor-Based Stock Analysis

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-17 10:34:46

AbbVie (NYSE:ABBV) Price Target Raised to $245.00

AbbVie (NYSE:ABBV – Get Free Report) had its target price boosted by equities researchers at Cantor Fitzgerald from $215.00 to $245.00 in a research note issued to investors on Monday, MarketBeat reports. The brokerage currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective points to a potential upside of 13.28% from the […] - 2025-09-17 02:56:46

ABBV Quantitative Stock Analysis

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-16 10:32:29

Validea Detailed Fundamental Analysis - ABBV

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-12 10:32:52

Company News for Sep 12, 2025

Companies in The News Are: TSLA, WBD, DOW, ABBV - 2025-09-12 10:18:00

The Best Stocks to Invest $50,000 In Right Now

Key PointsAbbVie is a Dividend King that's proven its resilience. - 2025-09-12 05:46:00

Notable Thursday Option Activity: ABBV, LRCX, UAL

Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in AbbVie Inc (Symbol: ABBV), where a total volume of 26,476 contracts has been traded thus far today, a contract volume which is representative of approximately 2.6 - 2025-09-11 14:43:20

Noteworthy ETF Inflows: VONG, ABBV, HD, RCL

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Russell 1000 Growth ETF (Symbol: VONG) where we have detected an approximate $454.7 million dollar inflow -- that's a 1.4% increase week ove - 2025-09-10 11:51:17

ABBV Factor-Based Stock Analysis

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-10 10:34:13

Daily Dividend Report: VZ,ESS,AVGO,SACH,ABBV,NUE

The Board of Directors at Verizon Communications today declared a quarterly dividend of 69 cents per outstanding share, an increase of 1.25 cents per share from the previous quarter. The quarterly dividend is payable on November 3, 2025 to Verizon shareholders of record at the c - 2025-09-05 12:59:15

Guru Fundamental Report for ABBV

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-04 10:32:24

Validea Detailed Fundamental Analysis - ABBV

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-29 10:33:22

ABBV Factor-Based Stock Analysis

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-27 10:34:48

As the Market Rotates, This Healthcare ETF Is Leading the Way

Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00

ABBV Quantitative Stock Analysis

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-26 10:34:00

Noteworthy ETF Inflows: SSO, ABBV, BAC, KO

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra S&P500 (Symbol: SSO) where we have detected an approximate $147.7 million dollar inflow -- that's a 2.1% increase week over week - 2025-08-25 13:36:49

Validea Detailed Fundamental Analysis - ABBV

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-22 10:34:21

ABBV Factor-Based Stock Analysis

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-20 10:33:59

Noteworthy ETF Outflows: ACWI, ABBV, BAC, KO

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $160.0 million dollar outflow -- that's a 0.7% decrease week over week (f - 2025-08-15 11:48:20

Validea Detailed Fundamental Analysis - ABBV

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-15 10:31:59

3 Dividend Stocks to Double Up On Right Now

Key PointsAbbVie is a Dividend King with an especially attractive valuation. - 2025-08-15 05:53:00

ABBV Quantitative Stock Analysis

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-12 10:33:16

4 of My Favorite Dividend Stocks for the Next 5 Years

My favorite type of dividend stock to invest in is dividend growth stocks. I like companies that pay safe, reliable, and growing dividends. I care less about yield and more about dividend growth. - 2025-08-09 10:42:00

iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) ABBV holdings

Date	Number of ABBV Shares Held	Base Market Value of ABBV Shares	Local Market Value of ABBV Shares	Change in ABBV Shares Held	Change in ABBV Base Value	Current Price per ABBV Share Held	Previous Price per ABBV Share Held
2025-10-20 (Monday)	872,043	USD 202,366,299	USD 202,366,299
2025-10-17 (Friday)	872,043	USD 200,194,912	USD 200,194,912	-3,924	USD 1,464,279	USD 229.57	USD 226.87
2025-10-16 (Thursday)	875,967	USD 198,730,633	USD 198,730,633	4,905	USD 1,678,987	USD 226.87	USD 226.22
2025-10-15 (Wednesday)	871,062	USD 197,051,646	USD 197,051,646	6,867	USD -961,354	USD 226.22	USD 229.13
2025-10-14 (Tuesday)	864,195	USD 198,013,000	USD 198,013,000	981	USD -785,184	USD 229.13	USD 230.3
2025-10-13 (Monday)	863,214	USD 198,798,184	USD 198,798,184
2025-10-08 (Wednesday)	853,404	USD 197,341,141	USD 197,341,141
2025-10-07 (Tuesday)	850,461	USD 198,012,835	USD 198,012,835	0	USD 2,245,217	USD 232.83	USD 230.19
2025-10-06 (Monday)	850,461	USD 195,767,618	USD 195,767,618	4,905	USD -2,016,386	USD 230.19	USD 233.91
2025-10-03 (Friday)	845,556	USD 197,784,004	USD 197,784,004	1,938	USD -1,782,270	USD 233.91	USD 236.56

Share Trades of ABBV by Blackrock for IE00B43HR379

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-17	SELL	-3,924			229.570*		192.93 Profit of 757,069 on sale
2025-10-16	BUY	4,905			226.870*		192.76
2025-10-15	BUY	6,867			226.220*		192.60
2025-10-14	BUY	981			229.130*		192.41
2025-10-06	BUY	4,905			230.190*		192.02
2025-10-03	BUY	1,938			233.910*		191.80
2025-10-02	BUY	969			236.560*		191.57
2025-10-01	BUY	5,652			244.380*		191.30
2025-09-24	BUY	1,930			219.990*		190.47
2025-09-18	BUY	968			221.990*		190.30
2025-09-11	BUY	967			220.220*		189.83
2025-09-10	BUY	967			211.640*		189.72
2025-08-26	BUY	3,868			208.360*		189.28
2025-08-20	BUY	1,934			209.150*		188.83
2025-08-19	BUY	967			206.190*		188.73
2025-08-01	SELL	-978			195.220*		188.69 Profit of 184,543 on sale
2025-07-30	BUY	977			189.310*		188.69
2025-07-17	SELL	-978			191.400*		188.69 Profit of 184,535 on sale
2025-07-15	SELL	-3,912			186.390*		188.69 Profit of 738,151 on sale
2025-07-14	SELL	-9,770			191.520*		188.67 Profit of 1,843,321 on sale
2025-07-09	SELL	-978			190.620*		188.60 Profit of 184,448 on sale
2025-07-07	SELL	-1,956			187.630*		188.60 Profit of 368,892 on sale
2025-07-02	BUY	978			190.750*		188.57
2025-06-24	SELL	-16,660			185.550*		188.69 Profit of 3,143,520 on sale
2025-06-23	BUY	980			183.760*		188.72
2025-06-20	BUY	5,257			185.300*		188.74
2025-06-18	SELL	-972			185.490*		188.79 Profit of 183,501 on sale
2025-06-17	BUY	11,652			185.480*		188.81
2025-06-13	SELL	-1,942			191.080*		188.78 Profit of 366,610 on sale
2025-06-11	SELL	-971			191.500*		188.73 Profit of 183,261 on sale
2025-06-10	SELL	-1,942			189.500*		188.73 Profit of 366,512 on sale
2025-06-09	SELL	-2,913			189.160*		188.73 Profit of 549,759 on sale
2025-05-21	SELL	-958			181.800*		189.07 Profit of 181,125 on sale
2025-05-20	SELL	-1,916			184.850*		189.10 Profit of 362,314 on sale
2025-05-15	SELL	-2,874			181.680*		189.23 Profit of 543,843 on sale
2025-05-14	SELL	-2,874			177.440*		189.33 Profit of 544,121 on sale
2025-05-13	BUY	958			188.000*		189.34
2025-05-09	SELL	-958			184.600*		189.37 Profit of 181,416 on sale
2025-05-08	BUY	1,916			185.580*		189.40
2025-05-01	BUY	1,916			193.340*		189.26
2025-04-24	SELL	-958			180.370*		189.25 Profit of 181,301 on sale
2025-04-23	BUY	2,874			177.050*		189.36
2025-04-15	SELL	-958			176.800*		190.33 Profit of 182,337 on sale
2025-04-10	SELL	-1,918			174.200*		190.77 Profit of 365,890 on sale
2025-04-08	SELL	-959			175.670*		191.04 Profit of 183,205 on sale
2025-04-07	SELL	-959			186.550*		191.08 Profit of 183,250 on sale
2025-04-04	SELL	-1,918			186.960*		191.13 Profit of 366,585 on sale
2025-04-02	BUY	959			205.190*		190.98
2025-04-01	BUY	8,631			206.270*		190.81
2025-03-31	SELL	-5,754			209.520*		190.61 Profit of 1,096,745 on sale
2025-03-28	BUY	959			205.290*		190.44
2025-03-26	SELL	-602			201.300*		190.18 Profit of 114,488 on sale
2025-03-21	BUY	9,053			210.010*		189.59
2025-03-20	BUY	3,824			211.960*		189.33
2025-03-17	SELL	-956			214.470*		188.43 Profit of 180,138 on sale
2025-03-12	SELL	-649			212.060*		187.53 Profit of 121,707 on sale
2025-03-07	BUY	954			214.290*		186.44
2025-02-28	SELL	-2,862			209.030*		185.11 Profit of 529,794 on sale
2025-02-25	BUY	9,540			204.140*		184.28
2025-02-20	BUY	6,678			200.880*		183.44
2025-02-19	BUY	2,862			197.350*		183.23
2025-02-18	BUY	1,908			196.250*		183.02
2025-02-13	BUY	4,765			193.450*		182.52
2025-02-04	BUY	3,812			189.950*		181.33
2025-01-31	BUY	953			183.900*		181.11
2025-01-29	BUY	953			175.260*		181.34
2025-01-27	BUY	1,906			176.900*		181.57
2025-01-24	BUY	953			170.300*		181.82
2025-01-22	BUY	3,812			169.200*		182.36
2024-12-10	SELL	-947			175.670*		184.93 Profit of 175,133 on sale
2024-12-09	SELL	-24,622			176.570*		185.20 Profit of 4,559,902 on sale
2024-12-03	SELL	-11,364			181.500*		186.28 Profit of 2,116,935 on sale
2024-12-02	SELL	-4,735			181.770*		186.45 Profit of 882,848 on sale
2024-11-29	SELL	-947			182.930*		186.59 Profit of 176,698 on sale
2024-11-22	SELL	-9,460			176.950*		188.09 Profit of 1,779,358 on sale
2024-11-21	SELL	-4,730			171.730*		188.91 Profit of 893,549 on sale
2024-11-20	BUY	7,568			167.760*		190.02
2024-11-18	SELL	-11,352			166.280*		192.80 Profit of 2,188,672 on sale
2024-11-11	BUY	8,514			174.430*		195.47
2024-11-08	SELL	-30,272			199.500*		195.18 Profit of 5,908,640 on sale
2024-11-07	SELL	-1,892			200.510*		194.78 Profit of 368,515 on sale
2024-11-01	SELL	-1,892			203.550*		191.69 Profit of 362,671 on sale
2024-10-31	SELL	-4,889			203.870*		190.16 Profit of 929,711 on sale
2024-10-30	BUY	946			201.500*		188.54
2024-10-29	BUY	5,676			189.450*		188.39
2024-10-28	SELL	-2,838			189.680*		188.14 Profit of 533,930 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ABBV

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer